article thumbnail

Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board

The Pharma Data

Pamer joined the University of Chicago from Memorial Sloan Kettering Cancer Center in New York City, where he served as head of the Division of Subspecialty Medicine from 2011 to 2018 and director of the Center for Microbes, Inflammation and Cancer from 2010 to 2019. Diversigen, Inc.

article thumbnail

Not all neoantigens are created equal

Drug Target Review

Recent advances in bioinformatics show clonal neoantigens are the best targets for immunotherapy, as I will elucidate below. Using powerful bioinformatics technology developed and validated with sequence data from the TRACERx study, researchers are able to identify clonal neoantigens from a patient’s unique tumour profile.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Codon Guide to Synthetic Biology

Codon

Nature Reviews Genetics (2010). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Nucleic Acids Research (2010). Science (2010). Molecular Systems Biology (2010). Nature (2010). . & Collins J.J. Link Is the cell really a machine? , by Nicholson D.J. & Weiss R.

DNA 98
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Nature Reviews Genetics (2010). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Nucleic Acids Research (2010). Journal of Biological Engineering (2010). Science (2010). Molecular Systems Biology (2010). Nature (2010). . & Collins J.J. by Nicholson D.J. PNAS (2008).

DNA 52